China orders tighter controls on production of Heparin

China's drug safety agency is ordering authorities to tighten controls on production of heparin, the blood-thinner linked to 19 deaths and hundreds of allergic reactions in the United States. China's order requires heparin producers to obtain the raw chemicals used to make the drug from registered suppliers. Raw heparin suppliers, meanwhile, are required to improve their management and tests on their products.